Drawing for ZELLBRIDGE

USPTO serial 79264488

ZELLBRIDGE

Reviewed by CopyMark Law Group

Reg. 6121131Status 700Renewal
Filing date
Status date
Registration date
Aug 11, 2020
Examiner
DYER, ERIN ZASKODA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ZELLBRIDGE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $850

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Howard N. Aronson

Howard N. Aronson Lackenbach Siegel LLP1 Chase Rd.Lackenbach Siegel Bldg.Scarsdale, NY 10583-4156

Goods and services

ClassDescriptionStatusFirst use
005Stem cells for medical and veterinary purposes; cells for medical and clinical use; living cells for medical purposes; pharmaceutical preparations for the treatment of central nervous system diseases and disorders; pharmaceutical preparations for the treatment of traumatic brain injury, cerebral infarction, cerebral hemorrhage, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury, and Alzheimer's disease; biological implants, namely, a vital processed human or animal connective tissue; surgical implants grown from stem cells; implants comprising living tissue; living tissue transplants in the nature of vascular grafts; human allograft tissues; processed human donor skins for the replacement of soft tissueACTIVE—
010Apparatus for the regeneration of stem cells for medical purposes; medical apparatus and instruments used for cell culture, namely, for cell culture chambers; medical apparatus and instruments, namely, cell testing apparatus in the nature of medical diagnostic apparatus for testing cancer cells, DNA, blood cells and extra cellular contents; medical apparatus and instruments, namely, intracellular material injector for medical purposes in the nature of injection instrument with needles, needle-based and needle-free injection systems; medical apparatus and instruments for monitoring vital signs, for use in orthopedic surgery; medical apparatus and instruments for analyzing substances for medical purposes, namely, blood and cell analyzers for medical diagnostics; medical apparatus and instruments, namely, test tubes for cell separation for medical purposes in the nature of blood testing apparatus, namely, blood sampling tubes; medical apparatus and instruments, namely, apparatus for the regeneration of stem cells for medical purposes; gene and genetic testing apparatus in the nature of apparatus for DNA and RNA testing for medical purposes; and medical apparatus and instruments, namely, cell injector for medical purposes in the nature of injection instrument with needles; medical apparatus and instruments, namely, needle-based and needle-free injection systems; implants consisting of artificial materials; artificial implants in the nature of surgical implants comprised of artificial materials and artificial vascular graftsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 17, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 11, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Dec 19, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 2, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 2, 2020FIMPFINAL DISPOSITION PROCESSED—
Nov 11, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 11, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 29, 2020GPNXNOTIFICATION PROCESSED BY IB—
May 26, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 26, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 13, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 13, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
May 6, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 18, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 12, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 12, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 11, 2020ALIEASSIGNED TO LIE—
Mar 9, 2020ALIEASSIGNED TO LIE—
Mar 3, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 28, 2019RFNTREFUSAL PROCESSED BY IB—
Sep 12, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 11, 2019RFRRREFUSAL PROCESSED BY MPU—
Aug 20, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 17, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 16, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 15, 2019DOCKASSIGNED TO EXAMINER—
Aug 15, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 8, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance